Literature DB >> 30474853

Class 1 HDAC and HDAC6 inhibition inversely regulates CD38 induction in myeloma cells via interferon-α and ATRA.

Ariunzaya Bat-Erdene1, Shingen Nakamura1, Asuka Oda1, Masami Iwasa1, Jumpei Teramachi1,2, Mohannad Ashtar3, Takeshi Harada1, Hirokazu Miki4, Hirofumi Tenshin1,3, Masahiro Hiasa1,3, Shiro Fujii1, Kimiko Sogabe1, Masahiro Oura1, Kengo Udaka1, Kumiko Kagawa1, Sumiko Yoshida1, Ken-Ichi Aihara1, Kiyoe Kurahashi1, Itsuro Endo1, Masahiro Abe1.   

Abstract

Entities:  

Keywords:  zzm321990ATRAzzm321990; CD38; HDAC inhibition; interferon-α; multiple myeloma

Mesh：

Substances：

Year:  2018        PMID： 30474853     DOI： 10.1111/bjh.15673

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  4 in total

Review 1.  CD38 Expression by Myeloma Cells and Its Role in the Context of Bone Marrow Microenvironment: Modulation by Therapeutic Agents.

Authors:  Federica Costa; Benedetta Dalla Palma; Nicola Giuliani
Journal:  Cells       Date:  2019-12-13       Impact factor: 6.600

2.  Treatment of therapy-related acute myeloid leukemia and underlying multiple myeloma with decitabine/venetoclax and daratumumab.

Authors:  Khalid Shoumariyeh; Johannes Jung; Michael Rassner; Sandra Maria Dold; Veronika Riebl; Milena Pantic; Georg Herget; Reinhard Marks; Michael Lübbert; Ralph Wäsch; Monika Engelhardt
Journal:  Ann Hematol       Date:  2021-03-13       Impact factor: 3.673

Review 3.  Promising Antigens for the New Frontier of Targeted Immunotherapy in Multiple Myeloma.

Authors:  Shih-Feng Cho; Lijie Xing; Kenneth C Anderson; Yu-Tzu Tai
Journal:  Cancers (Basel)       Date:  2021-12-06       Impact factor: 6.639

4.  The JAK-STAT pathway regulates CD38 on myeloma cells in the bone marrow microenvironment: therapeutic implications.

Authors:  Daisuke Ogiya; Jiye Liu; Hiroto Ohguchi; Keiji Kurata; Mehmet K Samur; Yu-Tzu Tai; Sophia Adamia; Kiyoshi Ando; Teru Hideshima; Kenneth C Anderson
Journal:  Blood       Date:  2020-11-12       Impact factor: 25.476
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.